Central nervous system infection caused by Mycobacterium houstonense: A case report

被引:3
作者
Wang, LiXia [1 ]
Wang, FaPing [1 ]
Yang, Chuan [2 ]
Luo, FengMing [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Resp & Crit Care Med, Chengdu, Peoples R China
[2] Sichuan Univ, Frontiers Sci Ctr Dis Related Mol Network, Lab Pulm Immunol & Inflammat, Chengdu, Peoples R China
基金
中国国家自然科学基金;
关键词
Mycobacteria houstonense; Mycobacterium fortuitum group; rapidly growing mycobacteria; central nervous system infection; next generation sequencing; 3RD BIOVARIANT COMPLEX; DRUG SUSCEPTIBILITY; INTERFERON-GAMMA; TUBERCULOSIS; RESISTANCE; FORTUITUM; DIAGNOSIS; MENINGITIS; CHELONAE; DISEASE;
D O I
10.3389/fneur.2022.908086
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundMycobacterium houstonense is a rapidly growing mycobacterium (RGM) that belongs to the unnamed third biovariant complex of the Mycobacterium fortuitum group, which is rarely responsible for human infection. Approximately 76% of infections caused by the M. fortuitum group occur after open fractures or skin, soft tissue, bone, or puncture wounds. To date, only a few cases of human infectious disease caused by M. houstonense have been reported worldwide. Case presentationWe present a case of a 26-year-old man with a central nervous system (CNS) infection caused by M. houstonense. The patient was transferred to our hospital because of headaches and muscle strength changes. One month prior to presentation at our hospital, the patient was diagnosed with tuberculous meningitis at the other two hospitals, but his condition did not improve after anti-tuberculous treatment, antibiotics, and anti-viral treatment before admission to our hospital. Lumbar puncture was performed at both previous hospitals, as well as at our hospital; the results consistently indicated high cerebrospinal fluid (CSF) opening pressure. M. houstonense was detected in the CSF of the second hospital's lumbar puncture by metagenomic next-generation sequencing (mNGS) but was not identified at our hospital. The patient was discharged from our hospital after receiving non-tuberculous mycobacterium (NTM) treatment for 1 month according to the Chinese NTM guidelines. However, the patient died 20 days after discharge. ConclusionSince it is difficult to identify M. houstonense, this is the first case of human CNS infection caused by M. houstonense in China. This case may be considered by neurologists and infectious physicians when CNS infection does not respond to conventional treatment, especially in the uncommon type of NTM.
引用
收藏
页数:10
相关论文
共 41 条
[31]   Surgical wound infection following open humeral fracture caused by Mycobacterium houstonense: a case report [J].
Tian, Lei ;
Zhang, Zhen ;
Chen, Zhongju ;
Sun, Ziyong .
BMC INFECTIOUS DISEASES, 2019, 19 (1)
[32]   Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria [J].
van Ingen, Jakko ;
Boeree, Martin J. ;
van Soolingen, Dick ;
Mouton, Johan W. .
DRUG RESISTANCE UPDATES, 2012, 15 (03) :149-161
[33]   Idiopathic CD4 lymphocytopenia [J].
Walker, Ulrich A. ;
Warnatz, Klaus .
CURRENT OPINION IN RHEUMATOLOGY, 2006, 18 (04) :389-395
[34]   CLINICAL-DISEASE, DRUG SUSCEPTIBILITY, AND BIOCHEMICAL PATTERNS OF THE UNNAMED 3RD BIOVARIANT COMPLEX OF MYCOBACTERIUM-FORTUITUM [J].
WALLACE, RJ ;
BROWN, BA ;
SILCOX, VA ;
TSUKAMURA, M ;
NASH, DR ;
STEELE, LC ;
STEINGRUBE, VA ;
SMITH, J ;
SUMTER, G ;
ZHANG, Y ;
BLACKLOCK, Z .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (03) :598-603
[35]   SUSCEPTIBILITIES OF MYCOBACTERIUM-FORTUITUM BIOVAR FORTUITUM AND THE 2 SUBGROUPS OF MYCOBACTERIUM-CHELONAE TO IMIPENEM, CEFMETAZOLE, CEFOXITIN, AND AMOXICILLIN-CLAVULANIC ACID [J].
WALLACE, RJ ;
BROWN, BA ;
ONYI, GO .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (04) :773-775
[36]   Comparison of the in vitro activity (formerly GAR-936) with those of tetracycline, minocycline, and deoxycycline against isolates of nontuberculous mycobaceria [J].
Wallace, RJ ;
Brown-Elliott, BA ;
Crist, CJ ;
Mann, L ;
Wilson, RW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (10) :3164-3167
[37]   Activities of linezolid against rapidly growing mycobacteria [J].
Wallace, RJ ;
Brown-Elliott, BA ;
Ward, SC ;
Crist, CJ ;
Mann, LB ;
Wilson, RW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) :764-767
[38]  
Wang XJ Li YH, 2020, ZHONGHUA LIU XING BI, V41, P856, DOI [10.3760/cma.j.cn112338-20190809-00587, DOI 10.3760/CMA.J.CN112338-20190809-00587]
[39]   Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis [J].
Wilson, M. R. ;
Sample, H. A. ;
Zorn, K. C. ;
Arevalo, S. ;
Yu, G. ;
Neuhaus, J. ;
Federman, S. ;
Stryke, D. ;
Briggs, B. ;
Langelier, C. ;
Berger, A. ;
Douglas, V. ;
Josephson, S. A. ;
Chow, F. C. ;
Fulton, B. D. ;
DeRisi, J. L. ;
Gelfand, J. M. ;
Naccache, S. N. ;
Bender, J. ;
Bard, J. Dien ;
Murkey, J. ;
Carlson, M. ;
Vespa, P. M. ;
Vijayan, T. ;
Allyn, P. R. ;
Campeau, S. ;
Humphries, R. M. ;
Klausner, J. D. ;
Ganzon, C. D. ;
Memar, F. ;
Ocampo, N. A. ;
Zimmermann, L. L. ;
Cohen, S. H. ;
Polage, C. R. ;
DeBiasi, R. L. ;
Haller, B. ;
Dallas, R. ;
Maron, G. ;
Hayden, R. ;
Messacar, K. ;
Dominguez, S. R. ;
Miller, S. ;
Chiu, C. Y. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (24) :2327-2340
[40]   Metagenomic Next -Generation Sequencing (mNGS) in cerebrospinal fluid for rapid diagnosis of Tuberculosis meningitis in HIV-negative population [J].
Yan, Liping ;
Sun, Wenwen ;
Lu, Zhenhui ;
Fan, Lin .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 96 :270-275